Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-01-25
2009-11-24
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S165000, C514S533000, C560S011000, C558S275000
Reexamination Certificate
active
07622502
ABSTRACT:
The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H) furanones useful in the treatment of cyclooxygenase-2 mediated diseases.The invention also encompasses certain pharmaceutical compositions and methods for treating cyclooxygenase-2 mediated diseases comprising the use of compounds of Formula I. The above compounds may be used as a combination therapy with low-dose aspirin to treat chronic cyclooxygenase-2 mediated diseases or conditions while also reducing the risk of thrombotic cardiovascular events.
REFERENCES:
patent: 7169809 (2007-01-01), Berthelette et al.
patent: WO 95/30641 (1995-11-01), None
patent: WO 97/28120 (1997-08-01), None
patent: WO 98/09948 (1998-03-01), None
patent: WO 01/45703 (2001-06-01), None
patent: WO 03/084550 (2003-10-01), None
patent: WO 03/103602 (2003-12-01), None
patent: WO 2004/002420 (2004-01-01), None
patent: WO 2004/011421 (2004-02-01), None
patent: WO 2004/103955 (2004-12-01), None
Beaulieu Christian
Berthelette Carl
Li Lianhai
Sturino Claudio F.
Wang Zhaoyin
Camara Valerie J.
Merck Frosst Canada & Co.
Panzer Curtis C.
Rodriguez-Garcia Valerie
Saeed Kamal A
LandOfFree
Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4059756